[Immunocytochemical and molecular detection of minimal residual disease in blood and bone marrow in colorectal cancer].
Immunocytochemical and molecular biological methods to analyze minimal residual disease (MRD) in colorectal cancer in blood and bone marrow were compared. The concept of a study in the Donauspital will be presented which will permit a comparative judgement of minimal residual disease in blood and bone marrow in patients with colorectal cancer.
Buxhofer
Veronika
V
Medizinische Abteilung, Donauspital im SMZ-Ost der Stadt Wien, Langobardenstrasse 122, A-1220 Wien. veronika.buxhofer@smz.magwien.gv.at
Ausch
C
C
Ogris
E
E
Schiessel
R
R
Hinterberger
W
W
D001853:Bone Marrow / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000235:genetics / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008967:Molecular Biology / Q000379:methods; D018365:Neoplasm, Residual / Q000097:blood* / Q000473:pathology*